Search

Your search keyword '"Carpino G"' showing total 508 results

Search Constraints

Start Over You searched for: Author "Carpino G" Remove constraint Author: "Carpino G"
508 results on '"Carpino G"'

Search Results

1. Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients

2. Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients

3. OC.06.2: POTENTIALOFA NATURAL COMPOUNDAS HEDGEHOG PATHWAY INHIBITOR FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA

5. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

7. Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients

8. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

9. The Italian law on body donation: A position paper of the Italian College of Anatomists

11. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

12. Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis

13. Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach

14. DCLK1, a putative novel stem cell marker in human cholangiocarcinoma

15. Oncogenic signaling pathways in the Cancer Genome Atlas

16. Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment

17. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

18. Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel

19. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

22. Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

23. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

24. FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

27. PC.01.6 HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES

28. Human duodenal submucosal glands contain stem cells with potential for liver and pancreatic regenerative medicine

29. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

30. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma

31. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

32. Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy

33. Anatomia Umana. Raccolta di quesiti a risposta multipla per la verifica e l'autoverifica degli apprendimenti SSD BIO-16

35. Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures

38. Different micro-environtmental factors induce proliferation, epithelial-mesenchymal transition (EMT) and senescence of primary cultures of human biliary tree stem/progenitor cells (hBTSCs), recapitulating the pathological features typical of human cholangiopathies

39. Pre-treatment risk stratification in primary biliary cholangitis: a predictive model to guide first-line combination therapy

40. OC.08.2 THE FXR AGONIST, OBETICHOLIC ACID, INHIBITS THE CANCEROGENIC POTENTIAL OF PRIMARY HUMAN CHOLANGIOCARCINOMA CELLS: A STUDY ON PRIMARY HUMAN CELL CULTURES

41. P.04.6 PRIMARY HUMAN BILIARY TREE STEM/PROGENITOR CELLS (HBTSCS) EXPOSED TO MICROENVIRONMENTAL FACTORS SHOWED PROLIFERATION, EPITHELIAL-MESENCHYMAL TRANSITION (EMT) AND SENESCENCE, RECAPITULATING THE PATHOLOGICAL FEATURES TYPICAL OF HUMAN CHOLANGIOPATHIES

43. OC.08.1 DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS

44. Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects

46. The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist

47. The exposure of primary cultures of human biliary tree stem/progenitor cells (hBTSCs) to different micro-environmental factors induces proliferation, epithelial-mesenchymal transition (EMT) and senescence, which are typical pathological features of human cholangiopathies

48. Taurocholate Feeding to Bile Duct Ligated Rats Prevents Caffeic Acid-Induced Bile Duct Damage by Changes in Cholangiocyte VEGF Expression

49. P.10.4: The Differentiation and Metabolism of Human Hepatic and Biliary Tree Stem/Progenitor Cells can be Significantly Modulated by Microgravity

Catalog

Books, media, physical & digital resources